1Nseir S,Di Pompeo C,Cavestri B,et al.Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmona-ry disease:prevalence,risk factors,and outcome(J).Crit Care Med,2006;34(12):2959-66.
2Sharma S,Anthonisen N.Role of antimicrobial agents in the management of exacerbations of COPD(J).Treat Respir Med,2005;4(3):153-67.
3Rivera-Fernandez R,Navarrete-Navarro P,Fernandez-Mondejar E,et al.Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease(J).Crit Care Med,2006;34(9):2317-24.
4Berkius J,Nolin T,Mrdh C,et al.Characteristics and long-term outcome of acute exacerbations in chronic obstructive pulmonary disease:an analy-sis of cases in the Swedish Intensive Care Registry during 2002-2006(J).Acta Anaesthesiol Scand,2008;52(6):759-65.
8Wedzicha JA, Seemungal TA. COPD exacerbations: defi- ning their cause and prevention J. Lancet, 2007, 370 (9589) :786-796.
9Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseJ. N Engl J Med,2007,356(8) .775- 789.
10Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification[ J]. Am J Respir Crit Care Med, 2012, 156:975 -981.
